Natural Agents for Chemoprevention of Lung Cancer

Lung Cancer, Third Edition

Volumn , Issue , 2008, Pages 441-455

  Sharafkhaneh, Amir ^a,b   Velamuri, Suryakanta ^a,b   Moghaddam, Seyed Javad ^c   Badmaev, Vladimir ^d   Dickey, Burton ^c   Kurie, Jonathan ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Sabinsa Pharmaceutical Inc   (United States)

Author keywords

Chemoprevention; Cytochrome; Lung cancer; Natural agents; Piperine

Indexed keywords

EID: 84889464617     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470696330.ch28     Document Type: Chapter

References (88)

1. Shaipanich T, McWilliams A, Lam S. Early detection and chemoprevention of lung cancer. Respirology 2006; 11(4):366-72.
2. Soler M, Bosetti C, Franceschi S et al. Fiber intake and the risk of oral, pharyngeal and esophageal cancer. Int J Cancer 2001; 91(3):283-7.
3. Levi F, Pasche C, La Vecchia C, Lucchini F, Franceschi S, Monnier P. Food groups and risk of oral and pharyngeal cancer. Int J Cancer 1998; 77(5):705-9.
4. Tavani A, Gallus S, La Vecchia C et al. Diet and risk of oral and pharyngeal cancer. An Italian case-control study. Eur J Cancer Prev 2001; 10(2):191-5.
5. Rylander R, Axelsson G. Lung cancer risks in relation to vegetable and fruit consumption and smoking. Int J Cancer 2006; 118(3):739-43.
6. Skuladottir H, Tjoenneland A, Overvad K, Stripp C, Olsen JH. Does high intake of fruit and vegetables improve lung cancer survival? Lung Cancer 2006; 51(3):267-73.
7. Brennan P, Hsu CC, Moullan N et al. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a Mendelian randomisation approach. Lancet 2005; 366(9496):1558-60.
8. Lee BM, Park KK. Beneficial and adverse effects of chemopreventive agents. Mutat Res 2003; 523-524:265-78.
9. Berge G, Ovrebo S, Botnen IV et al. Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer 2004; 91(2):333-8.
10. Allen SW, Mueller L, Williams SN, Quattrochi LC, Raucy J. The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression. Drug Metab Dispos 2001; 29(8):1074-9.
11. Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TF. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 2003; 9(2):64-76.
12. Preobrazhenskaia MN, Korolev AM. Indole derivatives in vegetables of the family Cruciferae. Bioorg Khim 2000; 26(2):97-111.
13. Morse JM. Expired research. Qual Health Res 2003; 13(5):595-6.
14. Kubin A, Wierrani F, Burner U, Alth G, Grunberger W. Hypericin-the facts about a controversial agent. Curr Pharm Des 2005; 11(2):233-53.
15. Dostalek M, Pistovcakova J, Jurica J et al. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver. Life Sci 2005; 78(3):239-44.
16. Gopalakrishna R, Chen ZH, Gundimeda U. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci U S A 1994; 91(25):12233-7.
17. Blank M, Lavie G, Mandel M, Keisari Y. Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. Oncol Res 2000; 12(9-10):409-18.
18. Zeng JZ, Sun DF, Wang L et al. Hypericum sampsonii induces apoptosis and nuclear export of retinoid X receptor-alpha. Carcinogenesis 2006; 27(10):1991-2000.
19. Selvendiran K, Thirunavukkarasu C, Singh JP, Padmavathi R, Sakthisekaran D. Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Mol Cell Biochem 2005; 271(1-2):101-6.
20. Selvendiran K, Prince Vijeya SJ, Sakthisekaran D. In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pulm Pharmacol Ther 2006; 19(2):107-11.
21. Selvendiran K, Banu SM, Sakthisekaran D. Oral supplementation of piperine leads to altered phase II enzymes and reduced DNA damage and DNA-protein cross links in Benzo(a)pyrene induced experimental lung carcinogenesis. Mol Cell Biochem 2005; 268(1-2):141-7.
22. Jin NZ, Zhu YP, Zhou JW et al. Preventive effects of quercetin against benzo[a]pyrene-induced DNA damages and pulmonary precancerous pathologic changes in mice. Basic Clin Pharmacol Toxicol 2006; 98(6):593-8.
23. Yang JH, Hsia TC, Kuo HM et al. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 2006; 34(2):296-304.
24. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004; 18(19):2273-81.
25. Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JL. Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther 2004; 310(2):528-35.
26. Singh RP, Banerjee S, Kumar PV, Raveesha KA, Rao AR. Tinospora cordifolia induces enzymes of carcinogen/ drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 2006; 13(1-2):74-84.
27. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124(4):823-35.
28. Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 2006; 3(6):535-7.
29. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003; 5(1):46-62.
30. Schabath MB, Delclos GL, Martynowicz MM et al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. AmJ Epidemiol 2005; 161(5):412-22.
31. Barnes PJ. Small airways in COPD. N Engl J Med 2004; 350(26):2635-7.
32. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364(9435):709-21.
33. Malkinson AM. Role of inflammation in mouse lung tumorigenesis: a review. Exp Lung Res 2005; 31(1):57-82.
34. Ji H, Houghton AM, Mariani TJ et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006; 25(14):2105-12.
35. Wislez M, Spencer ML, Izzo JG et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 2005; 65(8):3226-35.
36. Wislez M, Fujimoto N, Izzo JG et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006; 66(8):4198-207.
37. Houghton AM, Marconcini LA, Ji H, Wong KK, Shapiro SD. Neutrophil elastase causes increased mortality, angiogenesis, and lung tumor growth in a murine model of lung cancer [Abstract]. ProcAmThorac Soc 2006; 3:A479.
38. Moghaddam SJM, Tuvim M, DeMayo FJ, Dickey BF. Promotion of lung cancer progression by stimulation of innate immunity [Abstract]. ProcAm Thorac Soc 2006; 3: A458.
39. Kalpana C, Menon VP. Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol 2004; 56(5):581-6.
40. Kalpana C, Menon VP. Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 2004; 53(2):82-6.
41. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A):363-98.
42. Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, cmyc, bcl-XL, NF-kappa B, and p53. Clin Immunol 1999; 93(2):152-61.
43. Piwocka K, Zablocki K, Wieckowski MR et al. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 1999; 249(2):299-307.
44. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 2005; 7(1-2):32-41.
45. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003; 24(7):1269-79.
46. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995; 270(42):24995-5000.
47. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107(3):241-6.
48. Garg A, Aggarwal BB. Nuclear transcription factorkappaB as a target for cancer drug development. Leukemia 2002; 16(6):1053-68.
49. Giri DK, Aggarwal BB. Constitutive activation of NFkappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 1998; 273(22):14008-14.
50. Chen HW, Yu SL, Chen JJ et al. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 2004; 65(1):99-110.
51. Perkins S, Verschoyle RD, Hill K et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2002; 11(6):535-40.
52. Mahmoud NN, Carothers AM, Grunberger D et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000; 21(5):921-7.
53. Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 1995; 95(1-2):221-5.
54. Cheng AL, Hsu CH, Lin JK et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21(4B):2895-900.
55. Ireson C, Orr S, Jones DJ et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol esterinduced prostaglandin E2 production. Cancer Res 2001; 61(3):1058-64.
56. Sharma RA, McLelland HR, Hill KA et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7(7):1894-900.
57. Kim SO, Kundu JK, Shin YK et al. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol esterstimulated mouse skin. Oncogene 2005; 24(15):2558-67.
58. Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005; 24(46):6957-69.
59. Wang G, Li X, Huang F et al. Antitumor effect of betaelemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 2005; 62(7-8):881-93.
60. Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer 2006; 119(1):33-40.
61. Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol 2005; 55(1):33-8.
62. Kuo CL, Chi CW, Liu TY. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 2005; 19(1):247-52.
63. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006; 214(1):8-15.
64. Mitani N, Murakami K, Yamaura T, Ikeda T, Saiki I. Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett 2001; 165(1):35-42.
65. Takahashi T, Baba M, Nishino H, Okuyama T. Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells. Cancer Lett 2006; 231(2):319-25.
66. Ii T, Satomi Y, Katoh D et al. Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 2004; 207(1):27-35.
67. Hosoda A, Ozaki Y, Kashiwada A et al. Syntheses of ferulic acid derivatives and their suppressive effects on cyclooxygenase-2 promoter activity. Bioorg Med Chem 2002; 10(4):1189-96.
68. Lam S, McWilliams A, LeRiche J, Macaulay C, Wattenberg L, Szabo E. A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol Biomarkers Prev 2006; 15(8):1526-31.
69. Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NFkappa B-regulated gene expression. J Immunol 2006; 176(5):3127-40.
70. Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem 2004; 279(45):47148-58.
71. Zhu N, Rafi MM, DiPaola RS et al. Bioactive constituents from gum guggul (Commiphora wightii). Phytochemistry 2001; 56(7):723-7.
72. Mohammad RM, Al Katib A, Aboukameel A, Doerge DR, Sarkar F, Kucuk O. Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther 2003; 2(12):1361-8.
73. Seow A, Poh WT, Teh M et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002; 97(3):365-71.
74. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 2005; 65(15):6934-42.
75. Kang OH, Kim JA, Choi YA et al. Inhibition of interleukin-8 production in the human colonic epithelial cell line HT-29 by 18 beta-glycyrrhetinic acid. Int J Mol Med 2005; 15(6):981-5.
76. Maser E. Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol Sci 2004; 25(5):235-7.
77. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharide-induced nuclear factorkappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol 2000; 59(4):357-67.
78. Kuo PL, Hsu YL, Lin TC, Chang JK, Lin CC. Induction of cell cycle arrest and apoptosis in human nonsmall cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn. Anticancer Drugs 2005; 16(4):409-15.
79. Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005; 81(4):829-34.
80. Clark LC, Combs GF, Jr, Turnbull BW et al., for Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996; 276(24):1957-63.
81. Badmaev V, Majeed M, Passwater RA. Selenium: a quest for better understanding. Altern Ther Health Med 1996; 2(4):59-7.
82. Li L, Xie Y, El Sayed WM, Szakacs JG, Franklin MR, Roberts JC. Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J Biochem Mol Toxicol 2005; 19(6):396-405.
83. Brekhman II, Fulder S. Man and Biologically Active Substances: The Effect of Drugs, Diet, and Pollution on Health. New York: Pergamon, 1980.
84. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D. Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer. Cancer Sci 2006; 97(7):658-64.
85. Leyon PV, Kuttan G. Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother Res 2004; 18(2):118-22.
86. Yan Y, Wang Y, Tan Q et al. Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyreneinduced lung tumorigenesis in A/J mice. Neoplasia 2006; 8(1):52-8.
87. Panwar M, Samarth R, Kumar M, Yoon WJ, Kumar A. Inhibition of benzo(a)pyrene induced lung adenoma by panax ginseng extract, EFLA400, in Swiss albino mice. Biol Pharm Bull 2005; 28(11):2063-7.
88. Yun TK. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003; 523-524:63-74.